Skip to main content
Equibles

MARSHALL WACE, LLP

Position in BCYC — Bicycle Therapeutics PLC

CIK 1318757 LONDON, X0
Back to BCYC Full portfolio

Position in BCYC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,383,265
+$1,632,432 QoQ
Shares Held
797,940
+111.5% QoQ
Ownership
1.14%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 103 holders
Holding Since
Mar 2021
15 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in BCYC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,055,517,440 across 267 Biotechnology names. BCYC ranks #117 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 543,897 $270,169,956
2 INCY
Incyte Corp
 1,310,154 $148,519,056
3 RPRX
Royalty Pharma plc
 2,450,669 $137,409,009
4 SYRE
Spyre Therapeutics, Inc.
 991,693 $88,042,503
5 ALNY
Alnylam Pharmaceuticals, Inc.
 259,799 $78,207,292
6 TVTX
Travere Therapeutics, Inc.
 1,333,207 $75,739,488
7 MANE
Veradermics, Inc
 585,560 $71,988,746
8 DFTX
Definium Therapeutics, Inc.
 1,298,946 $61,102,419

All Filings in BCYC

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,383,265 797,940
2026-03-31 $1,750,833 377,335
2025-12-31 $274,667 38,795
2024-09-30 $7,473,738 330,258
2024-06-30 $1,801,096 88,987
2023-06-30 $236,595 9,271
2023-03-31 $1,630,323 76,649
2022-12-31 $274,421 9,271
2022-09-30 $215,643 9,271
2022-06-30 $1,344,463 80,123
2022-03-31 $465,961 10,619
2021-12-31 $3,067,726 50,398
2021-09-30 $319,993 7,694
2021-06-30 $233,589 7,694
2021-03-31 $654,660 21,917